Densiometric analysis of PHF-1 and total Tau showed 42% (p < 0.01) and 32% (p < 0.05) reduction respectively, by 2 g/Kg/d of HLJDT-M relative to vehicle-treated 3XTg-AD mice (Fig. 5b). This evidence concerns the gene MAPT and Alzheimer disease.